Dermatology and Therapy 3/2022

Open Access 04.02.2022 | Commentary

Atopic Dermatitis and Psoriasis are Diagnosed Clinically and Treated Empirically

Pushkar Aggarwal, Nathan L. Bowers, Suraj Muddasani, Alan B. Fleischer Jr., Steven R. Feldman

PDF-Version jetzt herunterladen Zum Volltext

Open Access 27.01.2022 | Original Research

Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma

Akimichi Morita, Chiharu Tateishi, Kyoko Ikumi, Daisuke Hayashi, Aya Nakada, Haruna Nishihara, Kan Torii, Emi Nishida, Daisuke Tsuruta

PDF-Version jetzt herunterladen Zum Volltext

Open Access 28.01.2022 | Original Research

Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents

Robert Sidbury, Sady Alpizar, Vivian Laquer, Sunil Dhawan, William Abramovits, Luca Loprete, Jayendar Kumar Krishnaswamy, Faiz Ahmad, Zarif Jabbar-Lopez, Christophe Piketty

PDF-Version jetzt herunterladen Zum Volltext

Open Access 05.02.2022 | Original Research

Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides

Carolina V. Alexander-Savino, Catherine G. Chung, Elaine S. Gilmore, Sean M. Carroll, Brian Poligone

PDF-Version jetzt herunterladen Zum Volltext

Open Access 29.01.2022 | Original Research

Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis

Xinyu Wang, Ming Zhang, Yu Chen, Yirong Liu, Yan Yu, Xiaojie Huang, Yanqing Gao

PDF-Version jetzt herunterladen Zum Volltext

Open Access 01.02.2022 | COVID-19 | Original Research

Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic

Maria Esposito, Anna Campanati, Alessandro Giunta, Gianluca Calianno, Luca Bianchi, Federico Diotallevi, Anna Maria Offidani, Maria Concetta Fargnoli

PDF-Version jetzt herunterladen Zum Volltext

Open Access 02.02.2022 | Original Research

An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study

Véronique Vendrely, Ander Mayor-Ibarguren, Aline Stennevin, Ariadna Ortiz-Brugués

PDF-Version jetzt herunterladen Zum Volltext

Open Access 26.02.2022 | Original Research

A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab

Andrew Blauvelt, Russel Burge, Gaia Gallo, Bridget Charbonneau, William Malatestinic, Baojin Zhu, Fangyu Wan, Benjamin Lockshin

PDF-Version jetzt herunterladen Zum Volltext

Open Access 17.02.2022 | Original Research

Effectiveness of Cimetidine as Adjuvant Therapy in the Treatment of Acute-Extrinsic Atopic Dermatitis: A Double-Blind Randomized Controlled Trial

Endi Novianto, Tjut N. A. Jacoeb, Wresti Indriatmi, Suhendro, Rianto Setiabudy, Rahajuningsih D. Setiabudy, Murdani Abdullah, Iris Rengganis, Oki Suwarsa, Retno W. Soebaryo

PDF-Version jetzt herunterladen Zum Volltext

Open Access 23.02.2022 | Original Research

Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis

Andrew Blauvelt, Melinda Gooderham, Christopher E. M. Griffiths, April W. Armstrong, Baojin Zhu, Russel Burge, Gaia Gallo, Jiaying Guo, Alyssa Garrelts, Mark Lebwohl

PDF-Version jetzt herunterladen Zum Volltext

Open Access 24.02.2022 | Original Research

Characteristics of New Biologic Users Among the Moderate-to-Severe Psoriasis Population—Retrospective Cohort Study Leveraging the Modernizing Medicine Data Services Database

Timothy Fitzgerald, Aimee M. Near, Hyunchung Kim, Amanda Teeple, Mobolaji Olurinde, Katelyn Rowland

PDF-Version jetzt herunterladen Zum Volltext

Open Access 07.03.2022 | Original Research

Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis

George Gondo, Edward Hadeler, Nicholas Brownstone, Emanual Maverakis, Joseph F. Merola, April W. Armstrong, Tina Bhutani, Stacie J. Bell, Wilson Liao

PDF-Version jetzt herunterladen Zum Volltext

Open Access 28.02.2022 | Original Research

Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

Laida Elberdín, Rosa M. Fernández-Torres, Sabela Paradela, María Mateos, Eva Blanco, Vanesa Balboa-Barreiro, María I. Gómez-Besteiro, Maria Outeda, Isabel Martín-Herranz, Eduardo Fonseca

PDF-Version jetzt herunterladen Zum Volltext

Open Access 17.03.2022 | Original Research

Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study

Andrew Alexis, Marjolein de Bruin-Weller, Stephan Weidinger, Weily Soong, Sebastien Barbarot, Ileana Ionita, Fan Zhang, Hernan Valdez, Claire Clibborn, Natalie Yin

PDF-Version jetzt herunterladen Zum Volltext

Open Access 15.02.2022 | Practical Approach

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17

April W. Armstrong, Andrew Blauvelt, Ulrich Mrowietz, Bruce Strober, Paolo Gisondi, Joseph F. Merola, Richard G. Langley, Mona Ståhle, Mark Lebwohl, Mihai G. Netea, Natalie Nunez Gomez, Richard B. Warren

PDF-Version jetzt herunterladen Zum Volltext

Open Access 15.02.2022 | COVID-19 | Case Report

A Case of New-Onset Lichen Planus after COVID-19 Vaccination

Vincenzo Picone, Gabriella Fabbrocini, Lorenzo Martora, Fabrizio Martora

PDF-Version jetzt herunterladen Zum Volltext

Springer Medizin

Dermatology and Therapy

Ausgabe 3/2022

Inhaltsverzeichnis (16 Artikel)

Atopic Dermatitis and Psoriasis are Diagnosed Clinically and Treated Empirically

Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma

Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents

Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides

Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis

Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic

An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study

A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab

Effectiveness of Cimetidine as Adjuvant Therapy in the Treatment of Acute-Extrinsic Atopic Dermatitis: A Double-Blind Randomized Controlled Trial

Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis

Characteristics of New Biologic Users Among the Moderate-to-Severe Psoriasis Population—Retrospective Cohort Study Leveraging the Modernizing Medicine Data Services Database

Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis

Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17

A Case of New-Onset Lichen Planus after COVID-19 Vaccination

Aktuelle Ausgaben

Ausgabe 1/2023

Ausgabe 12/2022

Ausgabe 11/2022

Ausgabe 10/2022

Ausgabe 9/2022

Ausgabe 8/2022

Ausgabe 7/2022

Ausgabe 6/2022

Ausgabe 5/2022

Ausgabe 4/2022

Neu im Fachgebiet Innere Medizin

Hilfe übers Bronchoskop bei COPD – neue Verfahren im Überblick

Nach ICI-Therapie: Wie häufig ist Diabetes?

UFOs sind weitgehend harmlos, versichert Studie

Vorteile für präoperative Chemotherapie bei Kolon-Ca.

Update Innere Medizin

Update Innere Medizin